With an FDA approval reentry should be profitable.
Not
With an FDA approval reentry should be profitable.
Not for some people. It would mean that Berman won and that is not to be tolerated. That's what brought this about in the first place. On April 23 DECN was one of 27 companies suffering trading suspension -- something that can be appealed and was. But that was not acceptable to the cabal, who wanted DECN closed down and Berman thrown in jail.
Even as I write this post the cabal, with at least one member who posts here, is attempting to influence and manipulate the SEC. For them it just never stops and won't until DECN is put out of business by the SEC and/or the FDA. But the FDA passed, leaving only the SEC and their man Fredo. There is always someone who practices the rule of the bigger fool. And that's Fredo. He took the cabal's bait and swallowed it whole. That's why the DECN shareholder letter to the SEC is so important and will have huge effect with the SEC adults in upper management It is not the SEC's job to protect non-shareholding trouble makers. Singularity of purpose is a great trait except when it is singularity of evil purpose. Several at the SEC will wake up, if they haven't already, and realize that the cabal in addition to being cyber criminals, are also full time stock manipulators. That is their day job. And that will be the knock knock moment. Give it 45 days.
1
Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...
Continue Reading
A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...
Continue Reading
Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...
Continue Reading
Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...
Continue Reading
The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...
Continue Reading
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...
Continue Reading
Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...
Continue Reading
In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...
Continue Reading
Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...
Continue Reading
Top 5 Most Recently Viewed Articles
Lumina Gold Reports Annual Meeting Outcomes Lumina Gold Corp. (TSXV: LUM) (OTCQB: LMGDF) has recently concluded its annual general and special meeting of shareholders. The results showcase a significant level of confidence from its stakeholders in the company's direction and governance. This meeting, a vital event for the company, signifies the shareholders' engagement...
Continue Reading
B2Gold Corp. Announces a Strategic Offering of Convertible Senior Notes B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) has embarked on an exciting new phase by announcing the offering of convertible senior unsecured notes. This initiative is aimed at raising an impressive total of US$350 million, with an additional option for underwriters to acquire up to US$52.5...
Continue Reading
Nancy Morgan Joins Academy Securities Academy Securities, recognized as the nation’s first Post-9/11 veteran-owned investment bank, has announced a significant addition to its Advisory Board and Geopolitical Intelligence Group. The firm is honored to welcome Nancy Morgan, a prominent expert in national security and technological innovation, who has made a profound...
Continue Reading
Celebrating Achievements: NAC Thanksgiving Gathering Recently, a wonderful gathering took place where scholars, educators, and community members came together to reflect on the achievements fostered by the Nicholas Academic Centers (NAC). This year's Thanksgiving dinner celebrated the hard work and dedication of its graduates and their profound impact on the community. A...
Continue Reading
Implications of a Potential Trump Victory on Cryptocurrency Market As the political scene in the United States intensifies with the upcoming elections, the idea of former President Donald Trump winning a second term has raised some crucial questions for the cryptocurrency market. As cryptocurrencies have evolved and gained prominence in global finance, understanding how a...
Continue Reading
